Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disorders
US-12054549-B2 · Aug 6, 2024 · US
This page is not indexed by search engines while we improve data quality.
Bender Andrew patents
Bender Andrew is listed as an inventor on 8 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Bender Andrew |
| Total patents | 8 |
| First publication | Jun 16, 2016 |
| Latest publication | Aug 6, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disorders
US-2023322934-A1 · Oct 12, 2023 · US
Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disorders
US-11485786-B2 · Nov 1, 2022 · US
An enzymatic assay to measure long-term adherence to pre exposure prophylaxis and antiretroviral therapy
US-2022307066-A1 · Sep 29, 2022 · US
Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disorders
US-2020002424-A1 · Jan 2, 2020 · US
Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disorders
US-2019144547-A1 · May 16, 2019 · US
Assays for BTK inhibitors
US-10012650-B2 · Jul 3, 2018 · US
Assays for btk inhibitors
US-2016169894-A1 · Jun 16, 2016 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Merck Patent Gmbh | 7 |
| Univ Washington | 1 |
| Massachusetts Gen Hospital | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K16/2848 | 5 |
| C07K2317/24 | 5 |
| A61P17/02 | 5 |
| A61P11/00 | 5 |
| C07K2317/73 | 5 |